腸-脳相互作用の障害で報告された患者に対する恥の影響
Inês A Trindade1, Amanda Blomsten2, Sanna Nybacka2
1Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; EMBRACE Lab, Center for Health and Medical Psychology, Örebro University, Örebro, Sweden.
Gastroenterology
|August 21, 2025
まとめ
恥は腸-脳相互作用障害 (DGBI) の患者に重大な影響を及ぼし,不安や鬱や生活の質を悪化させます. 同情とセラピーを通じて 恥を扱うことは DGBI患者の結果の管理に 極めて重要です
科学分野:
- 精神体医学
- 胃腸内科
- 臨床心理学
背景:
- 腸-脳相互作用の障害 (DGBI) は 非常に汚名を浴びていますが 恥の役割は まだ十分に研究されていません
- 現存する文献では,汚名と恥の関係が認められていますが,腸内DGBIの内での恥に特に焦点を当てていません.
研究 の 目的:
- 腸と脳の相互作用に関する 恥の影響を調べるため
- 恥が腸の症状と 心理的社会的な結果の関係を どのように媒介し 調節するかを調べる
主な方法:
- スウェーデンの人口ベースの2つのサンプル:腸DGBI (n=537) とマッチした対照群 (n=1881) を利用した横断研究.
- 検証された自己報告スケールによるオンライン調査が行われました.
- 構造方程式モデリングは,メディエーション分析に使用され,モデレーション分析が行われました.
主要な成果:
- 腸のDGBIを患っている人は,対照群と比較して,恥ずかしさのレベルが著しく高いと報告しています.
- 恥は腸の症状と 一般的な不安,うつ病症状,生活の質,活動障害との関連を媒介しました
- 恥は腸の症状が 腸内特異的な不安や 鬱症状や生活の質に及ぼす影響を 悪化させました
結論:
- 恥は腸内DGBIの症状の重要な感情的な結果であり,患者によって報告された結果に影響します.
- 腸内DGBIの恥ずかしさを管理するために,共感的な医師と患者の関係と心理的介入が推奨されます.
- DGBIにおける恥の心理的影響に関するさらなる研究が必要である.
関連する概念動画
Irritable Bowel Syndrome I: Introduction
375
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
375
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
245
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
245
Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
Assessment of the Gastrointestinal System I: Subjective Data
279
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
279
Assessment of the Gastrointestinal System II: Health Perception Pattern
162
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
162


